156 related articles for article (PubMed ID: 15481448)
1. Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.
Sakata N; Kawa K; Kato K; Yabe H; Yabe M; Nagasawa M; Mugishima H; Kigasawa H; Tsuchida M; Akiyama Y; Morisima Y; Kodera Y; Kato S
Int J Hematol; 2004 Aug; 80(2):174-82. PubMed ID: 15481448
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
[TBL] [Abstract][Full Text] [Related]
5. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
[TBL] [Abstract][Full Text] [Related]
6. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
[TBL] [Abstract][Full Text] [Related]
7. Unrelated donor marrow transplantation for inborn errors.
Miano M; Porta F; Locatelli F; Miniero R; La Nasa G; Di Bartolomeo P; Giardini C; Messina C; Balduzzi A; Testi AM; Garbarino L; Lanino E; Crescenzi F; Zecca M; Dini G
Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S37-41. PubMed ID: 9630323
[TBL] [Abstract][Full Text] [Related]
8. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.
Gustafsson A; Remberger M; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 May; 25(10):1059-65. PubMed ID: 10828866
[TBL] [Abstract][Full Text] [Related]
9. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for genetic and metabolic disorders.
Schaison G; Bordigoni P; Leverger G
Nouv Rev Fr Hematol (1978); 1989; 31(2):119-23. PubMed ID: 2505227
[TBL] [Abstract][Full Text] [Related]
11. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.
Davies SM; Kollman C; Anasetti C; Antin JH; Gajewski J; Casper JT; Nademanee A; Noreen H; King R; Confer D; Kernan NA
Blood; 2000 Dec; 96(13):4096-102. PubMed ID: 11110679
[TBL] [Abstract][Full Text] [Related]
12. Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor.
Inamoto Y; Oba T; Miyamura K; Terakura S; Tsujimura A; Kuwatsuka Y; Tokunaga M; Kasai M; Murata M; Naoe T; Kodera Y
Int J Hematol; 2006 May; 83(4):356-62. PubMed ID: 16757439
[TBL] [Abstract][Full Text] [Related]
13. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
[TBL] [Abstract][Full Text] [Related]
14. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
15. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Kojima S; Matsuyama T; Kato S; Kigasawa H; Kobayashi R; Kikuta A; Sakamaki H; Ikuta K; Tsuchida M; Hoshi Y; Morishima Y; Kodera Y
Blood; 2002 Aug; 100(3):799-803. PubMed ID: 12130489
[TBL] [Abstract][Full Text] [Related]
16. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
[TBL] [Abstract][Full Text] [Related]
17. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation.
Souillet G; Rey S; Bertrand Y; Pujol M; Pondarré C; Bourgeot JP; Raba M; Eljaafari A; Chapuis F; Manel AM; Philippe N; Gebuhrer L
Bone Marrow Transplant; 2000 Jul; 26(1):31-43. PubMed ID: 10918403
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.
Mehta J; Singhal S; Gee AP; Chiang KY; Godder K; Rhee Fv Fv; DeRienzo S; O'Neal W; Lamb L; Henslee-Downey PJ
Bone Marrow Transplant; 2004 Feb; 33(4):389-96. PubMed ID: 14716338
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
